Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adults Aged 18-45 Years”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Early research (Phase 1)Study completedNCT01678287
What this trial is testing

Study of the Pharmacokinetics of ASP1941 and the Effect on Glucose Concentrations in Male and Female Young and Elderly Healthy Adults

Who this might be right for
Healthy VolunteersPharmacokinetics of ASP1941
Astellas Pharma Global Development, Inc. 65
Testing effectiveness (Phase 2)Study completedNCT03935204
What this trial is testing

Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Condylomata AcuminataCervical Cancer
Xiamen University 627
Early research (Phase 1)Study completedNCT03813940
What this trial is testing

Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Condylomata AcuminataCervical Cancer
Xiamen University 24
Early research (Phase 1)Study completedNCT01018459
What this trial is testing

Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkina Faso

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT02639351
What this trial is testing

Safety and Immunogenicity of an Aluminium Hydroxide/LHD153R Adjuvanted Meningococcal C-CRM197 Conjugate Vaccine

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 80
Large-scale testing (Phase 3)Study completedNCT00816049
What this trial is testing

ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy

Who this might be right for
Acute Lymphoblastic Leukemia
Rigshospitalet, Denmark 775
Early research (Phase 1)Looking for participantsNCT07663032
What this trial is testing

Evaluate the Safety, Reactogenicity, and Immune Response of the GSK Vaccines Institute for Global Health (GVGH) Quadrivalent Pan-Salmonella Vaccine With and Without Alum in Healthy Young Adults

Who this might be right for
Salmonella Infections
GlaxoSmithKline 196
Early research (Phase 1)Study completedNCT03945825
What this trial is testing

Flublok or Fluzone With Advax-CpG55.2 or AF03

Who this might be right for
InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 241
Testing effectiveness (Phase 2)Looking for participantsNCT07222670
What this trial is testing

A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age

Who this might be right for
Viral Respiratory InfectionViral Respiratory Illnesses
ENA Respiratory Pty Ltd 1,100
Post-approval studies (Phase 4)Temporarily pausedNCT05165732
What this trial is testing

Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 480
Large-scale testing (Phase 3)Study completedNCT00423046
What this trial is testing

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 1,106
Testing effectiveness (Phase 2)Study completedNCT00740155
What this trial is testing

Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults

Who this might be right for
Dengue VirusDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi Pasteur, a Sanofi Company 154
Early research (Phase 1)Study completedNCT05644067
What this trial is testing

Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic Country

Who this might be right for
Malaria
Swiss Tropical & Public Health Institute 40